Ibanescu Alina, Olariu Dragos-Ioan, Lutic Doina, Hulea Vasile, Dragoi Brindusa
TRANSCEND Research Center, Regional Institute of Oncology, 2-4 General Henri Mathias Berthelot, 700483 Iasi, Romania.
Faculty of Chemical Engineering and Environmental Protection, "Gheorghe Asachi" Technical University of Iasi, 73 Prof. D. Mangeron Bvd., 700050 Iasi, Romania.
ACS Omega. 2023 Jul 12;8(29):26102-26121. doi: 10.1021/acsomega.3c02288. eCollection 2023 Jul 25.
Layered double hydroxides (LDHs) or hydrotalcite-like compounds have attracted great attention for the delivery of anticancer drugs due to their 2D structure, exhibiting a high surface-to-volume ratio and a high chemical versatility. The drug is protected between the layers from which it is slowly released, thus increasing the therapeutic effect and minimizing the side effects associated to nonspecific targeting. This work aimed to design LDHs with Mg and Al (molar ratio of 2/1) in brucite-like layers, which retained fluorouracil (5-FU; 5-FU/Al = 1, molar ratio) in the interlayer gallery as the layers grow during the co-precipitation step of the synthesis. To rationally control the physicochemical properties, particularly the size of the crystallites, the aging step following the co-precipitation was performed under carefully controlled conditions by changing the time and temperature (i.e., 25 °C for 16 h, 100 °C for 16 h, and 120 °C for 24 h). The results revealed the achievement of the control of the size of the crystals, which are gathered in three different agglomeration systems, from tight to loose, as well as the loading degree of the drug in the final organic-inorganic hybrid nanomaterials. The role played by the factors and parameters affecting the drug-controlled release was highlighted by assessing the release behavior of 5-FU by changing the pH, solid mass/volume ratio, and ionic strength. The results showed a pH-dependent behavior but not necessarily in a direct proportionality. After a certain limit, the mass of the solid diminishes the rate of release, whereas the ionic strength is essential for the payload discharge.
层状双氢氧化物(LDHs)或类水滑石化合物因其二维结构、高比表面积和高化学多功能性而在抗癌药物递送方面备受关注。药物在层间得到保护,并从层间缓慢释放,从而提高治疗效果并将与非特异性靶向相关的副作用降至最低。这项工作旨在设计水镁石层中镁和铝摩尔比为2/1的LDHs,在合成的共沉淀步骤中,随着层的生长,层间通道中保留氟尿嘧啶(5-FU;5-FU/Al = 1,摩尔比)。为了合理控制物理化学性质,特别是微晶的尺寸,通过改变时间和温度(即25℃ 16小时、100℃ 16小时和120℃ 24小时)在仔细控制的条件下进行共沉淀后的老化步骤。结果表明,成功控制了晶体尺寸,晶体聚集在三种不同的团聚体系中,从紧密到松散,以及最终有机-无机杂化纳米材料中药物的负载程度。通过改变pH值、固质量/体积比和离子强度评估5-FU的释放行为,突出了影响药物控释的因素和参数所起的作用。结果显示了pH依赖性行为,但不一定是直接比例关系。超过一定限度后,固体质量会降低释放速率,而离子强度对于有效载荷的释放至关重要。